Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Management of advanced nodal disease following chemoradiation for head and neck squamous cell carcinoma: role of magnetic resonance imaging.

Lin D, Glastonbury CM, Rafaelian O, Eisele DW, Wang SJ.

J Otolaryngol. 2007 Dec;36(6):350-6.

PMID:
18076845
2.

Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.

Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, Scher RL.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1418-23.

PMID:
15050318
3.

Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck.

Lau H, Phan T, Mackinnon J, Matthews TW.

Arch Otolaryngol Head Neck Surg. 2008 Mar;134(3):257-61. doi: 10.1001/archoto.2007.49.

PMID:
18347249
4.

Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.

Yom SS, Machtay M, Biel MA, Sinard RJ, El-Naggar AK, Weber RS, Rosenthal DI.

Am J Clin Oncol. 2005 Aug;28(4):385-92.

PMID:
16062081
5.
6.

Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation.

Robbins KT, Doweck I, Samant S, Vieira F.

Arch Otolaryngol Head Neck Surg. 2005 Nov;131(11):965-9.

PMID:
16301367
7.

A planned neck dissection is not necessary in all patients with N2-3 head-and-neck cancer after sequential chemoradiotherapy.

Soltys SG, Choi CY, Fee WE, Pinto HA, Le QT.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):994-9. doi: 10.1016/j.ijrobp.2011.07.042. Epub 2011 Dec 2.

PMID:
22137026
8.

Neck dissection after radiochemotherapy in patients with locoregionally advanced head and neck cancer.

López Rodríguez M, Cerezo Padellano L, Martín Martín M, Couñago Lorenzo F.

Clin Transl Oncol. 2008 Dec;10(12):812-6.

PMID:
19068452
9.

Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.

Tsai TL, Chu PY, Tai SK, Wang YF, Yang MH, Wang LW, Lirng JF, Chang SY.

Jpn J Clin Oncol. 2011 Oct;41(10):1182-93. doi: 10.1093/jjco/hyr124. Epub 2011 Aug 23.

PMID:
21862506
10.

Selective neck dissection following adjuvant therapy for advanced head and neck cancer.

Mukhija V, Gupta S, Jacobson AS, Eloy JA, Genden EM.

Head Neck. 2009 Feb;31(2):183-8. doi: 10.1002/hed.20944.

PMID:
19031407
11.

Observations on control of N2 and N3 neck disease in squamous cell carcinoma of the head and neck by intra-arterial chemoradiation.

Weisman RA, Christen RD, Jones VE, Kerber CW, Seagren SL, Orloff LA, Glassmeyer SL, Howell SB, Robbins KT.

Laryngoscope. 1998 Jun;108(6):800-5.

PMID:
9628492
12.

Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.

Merlano M, Russi EG, Numico G, Colantonio I, Garrone O, Pelissero A, Granetto C, Gasco M, Di Costanzo G, Heouaine A, Vigna Taglianti R, Cipolat M.

Radiother Oncol. 2005 May;75(2):193-6. Epub 2004 Dec 9.

PMID:
16086909
13.

Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.

Goguen LA, Posner MR, Tishler RB, Wirth LJ, Norris CM, Annino DJ, Sullivan CA, Li Y, Haddad RI.

Arch Otolaryngol Head Neck Surg. 2006 May;132(5):526-31.

PMID:
16702569
14.

Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma.

Ahmed KA, Robbins KT, Wong F, Salazar JE.

Laryngoscope. 2000 Nov;110(11):1789-93.

PMID:
11081585
15.

Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation.

van der Putten L, van den Broek GB, de Bree R, van den Brekel MW, Balm AJ, Hoebers FJ, Doornaert P, Leemans CR, Rasch CR.

Head Neck. 2009 May;31(5):593-603. doi: 10.1002/hed.20987.

PMID:
19132716
16.

Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapy.

Yovino S, Settle K, Taylor R, Wolf J, Kwok Y, Cullen K, Ord R, Zimrin A, Strome S, Suntharalingam M.

Head Neck. 2010 Jan;32(1):46-52. doi: 10.1002/hed.21141.

PMID:
19484762
17.

Planned early neck dissection before radiation for persistent neck nodes after induction chemotherapy.

Thomas GR, Greenberg J, Wu KT, Moe K, Esclamado R, Bradford C, Carroll W, Eisbruch A, Urba S, Wolf GT.

Laryngoscope. 1997 Aug;107(8):1129-37.

PMID:
9261021
18.

Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.

Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J.

Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):861-7.

PMID:
15262764
19.

Planned postradiotherapy neck dissection in patients with advanced head and neck cancer.

Boyd TS, Harari PM, Tannehill SP, Voytovich MC, Hartig GK, Ford CN, Foote RL, Campbell BH, Schultz CJ.

Head Neck. 1998 Mar;20(2):132-7.

PMID:
9484944
20.

Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.

Frank DK, Hu KS, Culliney BE, Persky MS, Nussbaum M, Schantz SP, Malamud SC, Holliday RA, Khorsandi AS, Sessions RB, Harrison LB.

Laryngoscope. 2005 Jun;115(6):1015-20.

PMID:
15933512

Supplemental Content

Support Center